US FDA Slams Dr. Reddy’s Over Fudged Tests
This article was originally published in PharmAsia News
Executive Summary
The US drug regulator, the FDA, has come down heavily on India’s Dr. Reddy's Laboratories over fudged test results and for failing to reveal the existence of a testing lab, in just one in a series of recent negative events to hit the major Indian generics company.